Hikma Announces Expanded Licensing Agreement with Takeda for New Products in...

Hikma continues strong strategic execution and reiterates guidance

Landmark trial, EMPEROR-Preserved, demonstrates empagliflozin is the first therapy to show...

AstraZeneca COVID-19 vaccine approved in the EU as third dose booster...

Novartis presents significant study results during renowned Best of ESMO Conference...

Hikma expands licensing agreement with Celltrion for Remsima® subcutaneous formulation in...

Hikma continued strategic progress and updated full-year guidance following Custopharm acquisition

Janssen signs MoU with Ministry of Investment of Saudi Arabia establishing...

Hikma and Melinta Therapeutics sign exclusive licensing agreement for two novel...

Boehringer Ingelheim sees positive business momentum in 2020 despite impact of...

1234...7Page 3 of 7

Connect with us

1,839FansLike
243FollowersFollow
1,929FollowersFollow
30SubscribersSubscribe